Amlodipine Cost in New York 2026

What Does Amlodipine Actually Cost in New York Right Now?

Generic amlodipine 5 mg or 10 mg tablets run about $8 per month at New York retail pharmacies when paid out-of-pocket in 2026. Brand-name Norvasc carries a list price near $80 per month, though almost no cash-paying patient needs to pay that figure given the wide availability of generics and discount programs.

Amlodipine is a dihydropyridine calcium channel blocker approved by the FDA for hypertension and angina [1]. Because FDA exclusivity expired years ago, more than a dozen generic manufacturers compete in the U.S. market, which is the primary driver of the low cash price. The Eighth Joint National Committee (JNC 8) guidelines recommend thiazide diuretics, ACE inhibitors, ARBs, or calcium channel blockers as first-line agents for hypertension in most adults [2], and amlodipine fills that last slot at a cost that is accessible for most patients even without insurance.

Price varies by pharmacy chain and zip code within New York. Patients in Manhattan, Brooklyn, Queens, the Bronx, Staten Island, Long Island, and upstate cities such as Buffalo and Albany may see slightly different shelf prices, but discount cards typically normalize the effective cost to $4, $8 regardless of location [3].

The ASCOT-BPLA trial (N=19,257, Lancet 2005) demonstrated that amlodipine-based therapy reduced fatal and non-fatal strokes by 23% compared with atenolol-based therapy (P<0.0003), establishing the clinical value that continues to justify widespread prescribing of this drug class [4]. That trial outcome also explains why cardiologists and primary care physicians continue to favor amlodipine despite the existence of cheaper thiazides.

How New York Medicaid Covers Amlodipine

New York Medicaid covers amlodipine, but a prior authorization (PA) is required before the pharmacy can dispense it at no cost to the enrollee. The PA process asks prescribers to document that the patient has an approved indication, such as hypertension or chronic stable angina, and that the prescribed dose is within standard labeling.

New York's Medicaid Preferred Drug Program (PDP) places most generic calcium channel blockers on the preferred formulary tier with the PA requirement as the gating step [5]. Once approved, the cost to the Medicaid enrollee is $0 per fill at any participating pharmacy. Dual-eligible beneficiaries (Medicare and Medicaid) may access amlodipine through a Medicare Part D plan instead; most Part D plans place generic amlodipine on Tier 1, typically meaning a $0, $5 copay per month [6].

Prescribers initiating amlodipine for a Medicaid patient should submit the PA request with the ICD-10 code (I10 for primary hypertension or I20.x for angina) and documentation of baseline blood pressure or symptom history. Most PA decisions in New York Medicaid are returned within 24 to 72 hours for non-emergency requests [5].

The New York State Department of Health updates its Medicaid formulary quarterly. Physicians and patients should verify current PA criteria at the time of prescribing because tier placement and PA criteria can shift between publication dates [5].

Which Private Insurance Plans in New York Cover Amlodipine?

Nearly every private insurance plan sold on the New York State of Health exchange covers generic amlodipine, typically at Tier 1 (preferred generic) with a copay of $0, $10 per 30-day supply. Employer-sponsored plans generally mirror that placement because amlodipine appears on almost every commercial formulary in the country.

The Affordable Care Act requires most non-grandfathered health plans to cover preventive services without cost-sharing, and while antihypertensives are not universally zero-cost-share under that provision, the U.S. Preventive Services Task Force recommends screening for hypertension in adults 18 and older [7]. Many plans interpret that recommendation broadly and place first-line antihypertensives such as amlodipine at zero or minimal copay on their preventive formularies.

Patients with high-deductible health plans (HDHPs) may pay out-of-pocket until the deductible is met, in which case cash-pay discount cards often cost less than the adjudicated insurance price. A GoodRx or SingleCare card at a major New York chain pharmacy can price a 30-day supply of generic amlodipine 5 mg at $4, $6, which may undercut the insurance price during the deductible phase [3].

Specialty plans such as those offered through the Essential Plan (New York's coverage option for income-eligible individuals who do not qualify for Medicaid) also cover amlodipine at minimal or no cost to the member [8].

The Cheapest Ways to Get Amlodipine in New York

Several routes can get amlodipine to a New York patient for $0, $8 per month:

$4 generic programs. Walmart, Costco, and several regional pharmacy chains in New York offer amlodipine as part of their $4 or $10 generic programs for 30-day or 90-day supplies, respectively. No insurance card or discount card is needed; patients pay the flat program price directly at the counter.

GoodRx and SingleCare cards. Free discount cards available at goodrx.com or singlecare.com produce pharmacy-specific coupons. Prices at New York pharmacies in 2026 typically land at $4, $8 for a 30-day supply of generic amlodipine 5 mg or 10 mg [3]. These cards cannot be combined with insurance.

90-day mail-order supply. Most Part D plans and many commercial plans allow 90-day mail-order fills at a lower per-day cost than monthly retail fills. Patients stable on 5 mg or 10 mg once daily can request a 90-day supply from their prescriber and pay as little as one month's copay for three months of medication.

Patient assistance programs. Pfizer's RxPathways program provides brand-name Norvasc at reduced or no cost for uninsured or underinsured patients who meet income criteria. Applications are submitted at pfizerrxpathways.com. Income thresholds are updated annually; the 2026 figures should be confirmed directly with Pfizer [9].

Compounded amlodipine. Patients enrolled in specific telehealth or direct-care programs may receive compounded amlodipine through a licensed 503A pharmacy at $0 per month as part of a bundled membership fee. See the section below on legality and access.

The HealthRX Access Framework for amlodipine in New York ranks these options as follows for a cash-paying, uninsured adult: (1) $4 generic program at Walmart or Costco, (2) GoodRx coupon at CVS/Walgreens, (3) 90-day supply at Costco Pharmacy, (4) telehealth membership with bundled compounded amlodipine, (5) Pfizer RxPathways for brand Norvasc if generics are contraindicated for a documented clinical reason.

Is Compounded Amlodipine Legal in New York?

Compounded amlodipine is legal in New York when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription from a licensed prescriber. The New York State Board of Pharmacy enforces state compounding regulations, which run in parallel with FDA oversight of 503A facilities under the Drug Quality and Security Act of 2013 [10].

A 503A pharmacy compounds for individual patients; it does not produce large batches for general sale. Compounded amlodipine is most often dispensed as an oral suspension or a transdermal gel, which are formulations not commercially available in standard FDA-approved tablets. These alternative dose forms may serve patients who cannot swallow tablets, pediatric patients requiring weight-based dosing, or adults in specific telehealth programs that bundle the medication with a care membership [10].

The FDA has not placed amlodipine on the list of drugs that may not be compounded (the "negative list" under 21 U.S.C. 353a), so compounding is not categorically prohibited [10]. Prescribers must write a patient-specific prescription, and the 503A pharmacy must source amlodipine from an FDA-registered active pharmaceutical ingredient (API) supplier.

Patients should confirm that any compounding pharmacy they use holds a current New York State Board of Pharmacy license. The license lookup tool is available at the New York State Office of the Professions website. Telehealth companies operating in New York that advertise "free" or "$0" compounded amlodipine bundle the pharmacy cost into a monthly membership fee; the medication itself is not literally without cost to the system.

Can a New York Telehealth Provider Prescribe Amlodipine?

Yes. New York permits telehealth prescribing of controlled and non-controlled medications, and amlodipine is a non-controlled Schedule V or unscheduled medication with no DEA restrictions, so prescribing via synchronous or asynchronous telehealth is fully permitted under New York Public Health Law Article 29-G [11].

A prescriber must be licensed in New York, must establish a valid prescriber-patient relationship (which in New York may be done entirely via video or, under certain conditions, telephone), and must document a clinical encounter in which blood pressure or angina history was evaluated. Remote blood pressure monitoring data from consumer devices is acceptable supporting documentation, though prescribers typically ask patients to confirm readings on a validated cuff [12].

Telehealth visits for hypertension management typically cost $0, $75 in New York depending on insurance coverage. Many telehealth platforms accept New York Medicaid and major commercial insurance for the visit fee, then transmit the prescription to the patient's preferred pharmacy or to a bundled compounding pharmacy.

The American Heart Association's 2023 hypertension guidelines note that self-measured blood pressure monitoring "should be used to confirm hypertension diagnosis and guide treatment" [13], making remote monitoring a clinically appropriate component of telehealth-based amlodipine management.

Amlodipine Dosing and Clinical Context

Standard amlodipine dosing starts at 5 mg orally once daily for hypertension or chronic stable angina in adults, with titration to 10 mg once daily after 7 to 14 days if blood pressure or anginal symptoms remain uncontrolled [1]. The FDA-approved labeling also permits initiation at 2.5 mg once daily in small, fragile, or elderly patients and in patients with hepatic impairment [1].

The drug's long plasma half-life of 30 to 50 hours means once-daily dosing achieves a smooth 24-hour antihypertensive effect without significant peak-to-trough variation [1]. That pharmacokinetic profile reduces the clinical consequences of a missed dose, which is relevant for adherence counseling.

The ACCOMPLISH trial (N=11,506) found that the combination of amlodipine plus benazepril reduced the primary composite cardiovascular endpoint by 20% compared with benazepril plus hydrochlorothiazide (P<0.001) in high-risk hypertensive patients [14]. That finding supports amlodipine as a preferred combination partner in patients who need dual antihypertensive therapy.

Common adverse effects include peripheral edema (reported in 10.8% of patients at 10 mg in the FDA label), flushing, and palpitations [1]. Edema is dose-dependent and may be managed by dose reduction or by adding an ACE inhibitor or ARB, which counteracts the peripheral vasodilation mechanism.

Drug interactions of clinical note include CYP3A4 inhibitors such as clarithromycin, ketoconazole, and grapefruit juice, which may increase amlodipine plasma concentrations and potentiate hypotension [1]. Simvastatin dose should not exceed 20 mg per day when co-administered with amlodipine, per FDA safety labeling [15].

The American College of Cardiology and American Heart Association 2017 hypertension guideline recommends a blood pressure target of <130/80 mmHg for most adults, and amlodipine is listed as a first-line agent to achieve that target [13]. Patients who begin amlodipine for the first time should return for a blood pressure check or submit remote readings within 2 to 4 weeks of initiation to assess response.

New York-Specific Pharmacy Access Notes

New York City has one of the highest pharmacy densities in the United States, with over 2,000 retail pharmacy locations across the five boroughs [16]. That density creates genuine price competition, and patients willing to compare prices across nearby pharmacies or zip codes may find meaningful differences even without a discount card.

Upstate New York patients in rural counties served by independent pharmacies may face slightly higher shelf prices than chain pharmacies in urban areas, making discount cards proportionally more valuable in those regions. The New York State Medicaid Drug Utilization Review Board publishes quarterly data on the most frequently dispensed generic drugs; amlodipine consistently appears in the top 20 most-dispensed drugs statewide, reflecting the high prevalence of hypertension in the New York adult population [5].

The New York State Department of Financial Services regulates insurance policy formularies and can receive complaints about step-therapy or PA requirements that delay access to first-line medications such as amlodipine. Patients denied a PA on New York Medicaid have the right to a fair hearing under 18 NYCRR Part 358 [8].

Hypertension affects approximately 47% of U.S. adults according to the CDC, and the prevalence in New York adults is consistent with that national figure [17]. With nearly half of the adult population at potential need for antihypertensive therapy, broad, low-cost access to amlodipine is a population-level priority for New York's health system.